Ethambutol/isoniazid/rifampicin
Jump to navigation
Jump to search
| Combination of | |
|---|---|
| Ethambutol | Anti-tuberculosis medication |
| Isoniazid | Anti-tuberculosis medication |
| Rifampicin | Anti-tuberculosis medication |
| Clinical data | |
| Defined daily dose | not established[1] |
Ethambutol/isoniazid/rifampicin, also known as ethambutol/isoniazid/rifampin, is a fixed-dose combination medication used to treat tuberculosis.[2] It contains ethambutol, isoniazid, and rifampicin.[2] It is used either along or with other antituberculosis medication.[2] It is taken by mouth.[2] Side effects are those of the underlying medications.[2] Use may not be suitable in children.[2]
It is on the World Health Organization's List of Essential Medicines.[3] The wholesale cost in the developing world is about 6.74 to US$16.13 a month.[4]
Dosage
The defined daily dose is not established[1]
See also
References
- ↑ 1.0 1.1 "WHOCC - ATC/DDD Index". www.whocc.no. Archived from the original on 2 August 2020. Retrieved 18 September 2020.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 142. hdl:10665/44053. ISBN 9789241547659.
- ↑ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ↑ "Rifampicin + Isoniazid + Ethambutol". International Drug Price Indicator Guide. Archived from the original on 19 January 2019. Retrieved 8 December 2016.
External links
- "Ethambutol". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 2020-10-20. Retrieved 2020-10-06.
- "Isoniazid". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 2020-10-08. Retrieved 2020-10-06.
- "Rifampin". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 2020-08-12. Retrieved 2020-10-06.
| Identifiers: |
|
|---|
 | This antiinfective drug article is a stub. You can help MDWiki by expanding it. |
Categories:
- Pages using duplicate arguments in template calls
- Chemical articles with unknown parameter in Infobox drug
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- Chemicals that do not have a ChemSpider ID assigned
- Combination drugs
- Tuberculosis
- World Health Organization essential medicines
- RTT
- All stub articles
- Antiinfective agent stubs